162 related articles for article (PubMed ID: 32676400)
1. Serum and tissue syndecan-1 levels in renal cell carcinoma.
Niedworok C; Kempkensteffen C; Eisenhardt A; Tschirdewahn S; Rehme C; Panic A; Reis H; Baba H; Nyirády P; Hadaschik B; Kovalszky I; Szarvas T
Transl Androl Urol; 2020 Jun; 9(3):1167-1176. PubMed ID: 32676400
[TBL] [Abstract][Full Text] [Related]
2. Soluble syndecan-1 (SDC1) serum level as an independent pre-operative predictor of cancer-specific survival in prostate cancer.
Szarvas T; Reis H; Vom Dorp F; Tschirdewahn S; Niedworok C; Nyirady P; Schmid KW; Rübben H; Kovalszky I
Prostate; 2016 Aug; 76(11):977-85. PubMed ID: 27062540
[TBL] [Abstract][Full Text] [Related]
3. Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancer.
Szarvas T; Reis H; Kramer G; Shariat SF; Vom Dorp F; Tschirdewahn S; Schmid KW; Kovalszky I; Rübben H
Hum Pathol; 2014 Apr; 45(4):674-82. PubMed ID: 24656090
[TBL] [Abstract][Full Text] [Related]
4. Compartmental Syndecan-1 (CD138) expression as a novel prognostic marker in triple-negative metaplastic breast cancer.
Ismail Y; Zakaria AS; Allam R; Götte M; Ibrahim SA; Hassan H
Pathol Res Pract; 2024 Jan; 253():154994. PubMed ID: 38071886
[TBL] [Abstract][Full Text] [Related]
5. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
6. Circulating syndecan-1 is associated with chemotherapy-resistance in castration-resistant prostate cancer.
Szarvas T; Sevcenco S; Módos O; Keresztes D; Nyirády P; Kubik A; Romics M; Kovalszky I; Reis H; Hadaschik B; Shariat SF; Kramer G
Urol Oncol; 2018 Jun; 36(6):312.e9-312.e15. PubMed ID: 29628317
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and clinical significance of syndecan-1 expression in breast cancer: A systematic review and meta-analysis.
Qiao W; Liu H; Guo W; Li P; Deng M
Eur J Surg Oncol; 2019 Jul; 45(7):1132-1137. PubMed ID: 30598194
[TBL] [Abstract][Full Text] [Related]
8. Soluble Syndecan-1 Levels Are Associated with Survival in Platinum-Treated Bladder Cancer Patients.
Olah C; Tschirdewahn S; Hoffmann MJ; Krafft U; Hadaschik B; Nyirady P; Szendröi A; Módos O; Csizmarik A; Kovalszky I; Reis H; Szarvas T
Diagnostics (Basel); 2020 Oct; 10(11):. PubMed ID: 33114033
[TBL] [Abstract][Full Text] [Related]
9. Circulating syndecan-1 and glypican-4 predict 12-month survival in metastatic colorectal cancer patients.
Muendlein A; Severgnini L; Decker T; Heinzle C; Leiherer A; Geiger K; Drexel H; Winder T; Reimann P; Mayer F; Nonnenbroich C; Dechow T
Front Oncol; 2022; 12():1045995. PubMed ID: 36353562
[TBL] [Abstract][Full Text] [Related]
10. Syndecan-1 expression is associated with tumor size and EGFR expression in colorectal carcinoma: a clinicopathological study of 230 cases.
Kim SY; Choi EJ; Yun JA; Jung ES; Oh ST; Kim JG; Kang WK; Lee SH
Int J Med Sci; 2015; 12(2):92-9. PubMed ID: 25589885
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological Significance of Syndecan-1 in Cholangiocarcinoma: A Study Based on Immunohistochemistry and Public Sequencing Data.
Gerber TS; Bartsch F; Wagner DC; Schindeldecker M; Heuft LK; Roth W; Lang H; Straub BK
J Clin Med; 2021 Jun; 10(13):. PubMed ID: 34206469
[TBL] [Abstract][Full Text] [Related]
12. Loss of SDC1 Expression Is Associated with Poor Prognosis of Colorectal Cancer Patients in Northern China.
Li K; Li L; Wu X; Yu J; Ma H; Zhang R; Li Y; Wang W
Dis Markers; 2019; 2019():3768708. PubMed ID: 31182980
[TBL] [Abstract][Full Text] [Related]
13. Correlation of bFGF expression in renal cell cancer with clinical and histopathological features by tissue microarray analysis and measurement of serum levels.
Horstmann M; Merseburger AS; von der Heyde E; Serth J; Wegener G; Mengel M; Feil G; Hennenlotter J; Nagele U; Anastasiadis A; Bokemeyer C; Stenzl A; Kuczyk M
J Cancer Res Clin Oncol; 2005 Nov; 131(11):715-22. PubMed ID: 16080018
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of syndecan-1 expression in squamous cell carcinoma of the tonsil.
Lee SH; Choi EJ; Kim MS; Park JW; Lee YS; Kim SY; Kang CS
Int J Clin Oncol; 2014 Apr; 19(2):247-53. PubMed ID: 23553620
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of BAP1, PBRM1, pS6, PTEN, TGase2, PD-L1, CA9, PSMA, and Ki-67 tissue markers in localized renal cell carcinoma: A retrospective study of tissue microarrays using immunohistochemistry.
Kim SH; Park WS; Park EY; Park B; Joo J; Joung JY; Seo HK; Lee KH; Chung J
PLoS One; 2017; 12(6):e0179610. PubMed ID: 28654655
[TBL] [Abstract][Full Text] [Related]
16. Advances in the molecular functions of syndecan-1 (SDC1/CD138) in the pathogenesis of malignancies.
Gharbaran R
Crit Rev Oncol Hematol; 2015 Apr; 94(1):1-17. PubMed ID: 25563413
[TBL] [Abstract][Full Text] [Related]
17. Syndecan-1 expression by stromal fibroblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis.
Maeda T; Desouky J; Friedl A
Oncogene; 2006 Mar; 25(9):1408-12. PubMed ID: 16247452
[TBL] [Abstract][Full Text] [Related]
18. Association of Preoperative and Postoperative Plasma Syndecan-1 and Colorectal Cancer Outcome.
Tanaka H; Hayashi H; Tomita H; Tokumaru Y; Fukada M; Tajima JY; Yokoi R; Tsuchiya H; Kuno M; Sato Y; Yasufuku I; Asai R; Mori R; Tanaka Y; Okumura N; Futamura M; Matsuhashi N
Anticancer Res; 2024 Apr; 44(4):1611-1618. PubMed ID: 38537984
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Syndecan-1 Immunohistochemical Expression in Lobular and Ductal Breast Carcinoma with Nodal Metastases.
Miše I; Vučić M
Anal Cell Pathol (Amst); 2018; 2018():9432375. PubMed ID: 30151336
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
